About FDA
Percentage of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month
Dictionary: Timely review of regulatory cases that come from the field is important as it allows FDA to take appropriate regulatory action such as issuance of a warning letter to the regulated industry. This can lead to a timely correction of problems in the industry resulting in a safer food supply.
Information is current as of December 31, 2012.
Fiscal Year - 2013
| Time | Target | Percentage |
|---|---|---|
| Oct 2012 | 80 | 67 |
| Nov 2012 | 80 | 87 |
| Dec 2012 | 80 | 89 |
| Jan 2013 | 80 | TBD |
| Feb 2013 | 80 | TBD |
| Mar 2013 | 80 | TBD |
| Apr 2013 | 80 | TBD |
| May 2013 | 80 | TBD |
| Jun 2013 | 80 | TBD |
| Jul 2013 | 80 | TBD |
| Aug 2013 | 80 | TBD |
| Sep 2013 | 80 | TBD |
FY 2013 YTD: 82%
Total number of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct 2012 | N/A | 18 |
| Nov 2012 | N/A | 34 |
| Dec 2012 | N/A | 31 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 83
Total number of regulatory cases referred to OFS in the month that are due within the month
Fiscal Year - 2013
| Time | Target | Number |
|---|---|---|
| Oct 2012 | N/A | 27 |
| Nov 2012 | N/A | 39 |
| Dec 2012 | N/A | 35 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 101
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
